sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 551-575 out of 1404.

<< < 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 > >>

Public Release: 4-Jan-2017
None
MSU lands $1 million USAID grant to fight Zika
Michigan State University has landed a highly competitive grant from USAID to fight the Zika virus in Mexico.
US Agency for International Development

Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University

Public Release: 3-Jan-2017
American Journal of Clinical Nutrition
Zinc eaten at levels found in biofortified crops reduces 'wear and tear' on DNA
A new study by researchers from the UCSF Benioff Children's Hospital Research Institute (CHORI) shows that a modest 4 milligrams of extra zinc a day in the diet can have a profound, positive impact on cellular health that helps fight infections and diseases. This amount of zinc is equivalent to what biofortified crops like zinc rice and zinc wheat can add to the diet of vulnerable, nutrient deficient populations.

Contact: Melinda Krigel
mkrigel@mail.cho.org
510-428-3069
Children's Hospital & Research Center Oakland

Public Release: 3-Jan-2017
Journal of Medical Entomology
Why odds are against a large Zika outbreak in the US
Is the United States at risk for a large-scale outbreak of Zika or other mosquito-borne disease? While climate conditions in the US are increasingly favorable to mosquitos, socioeconomic factors such as access to clean water and air conditioning make large-scale outbreaks unlikely, according to new analysis of existing research -- but small-scale, localized outbreaks are an ongoing concern.
Indiana University-Purdue, University Indianapolis Chancellor for Research

Contact: Joe Rominiecki
jrominiecki@entsoc.org
301-731-4535 x3009
Entomological Society of America

Public Release: 2-Jan-2017
Current Drug Targets
Targeting legumain as a novel therapeutic strategy in cancers
This review will be the first to summarize the expression of legumain (LGMN) in common cancers, as well as its roles in tumourigenesis and metastasis. This review also discusses the current developments and future prospects of targeting LGMN through the development of DNA vaccines, azo-peptides, small molecule inhibitors and LGMN activated prodrugs, highlighting the potential of LGMN as a target for cancer therapeutics.

Contact: Faizan ul Haq
faizan@benthamscience.org
Bentham Science Publishers

Public Release: 2-Jan-2017
Proceedings of the National Academy of Sciences
For the first time, researchers identify key proteins that may make Zika so deadly
Now, a new study has for the first time identified seven key proteins in the virus that may be the culprits behind this damage. The study is the first comprehensive description of the Zika virus genome.

Contact: David Kohn
dkohn@som.umaryland.eduh
410-706-7590
University of Maryland School of Medicine

Public Release: 22-Dec-2016
Specific Technologies and FIND announce strategic collaboration
Specific Technologies and FIND today announced a collaboration to promote the development of new solutions for diagnosis of bloodstream infections in resource-poor environments.

Contact: Press Contact
press@specifictechnologies.net
650-938-2030
Specific Technologies

Public Release: 22-Dec-2016
PLOS Neglected Tropical Diseases
Deadly sleeping sickness set to be eliminated in 6 years
Gambian sleeping sickness -- a deadly parasitic disease spread by tsetse flies -- could be eliminated in six years in key regions in the Democratic Republic of Congo (DRC), according to new research by the University of Warwick.
Bill and Melinda Gates Foundation, Task Force for Global Health, Biotechnology and Biological Sciences Research Council, Department for International Development, The Economic & Social Science Research Council, The Natural Environment Research Council

Contact: Luke Walton
L.Walton.1@warwick.ac.uk
44-782-454-0863
University of Warwick

Public Release: 21-Dec-2016
Neurology
Challenges remain in HIV care in Africa
Barriers to diagnosis and lack of access to modern medications have combined to place caregivers and HIV-positive patients in sub-Saharan Africa between a rock and a hard place. A new study shows that physicians are often forced to choose between controlling seizures, which can occur if the disease goes undiagnosed for too long, or treating the underlying HIV infection.
Fogarty International Center and NIH/National Institute of Neurological Disorders and Stroke

Contact: Mark Michaud
mark_michaud@urmc.rochester.edu
585-273-4790
University of Rochester Medical Center

Public Release: 20-Dec-2016
NIH launches first large trial of a long-acting injectable drug for HIV prevention
The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today. The study, sponsored by NIH, will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every 8 weeks can safely protect men and transgender women from HIV infection at least as well as the anti-HIV medication Truvada taken daily as an oral tablet.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Laura S. Leifman
laura.sivitz@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 19-Dec-2016
Applied and Environmental Microbiology
DNA markers distinguish between harmless, deadly bacteria
Through a new study of the coccobacillus Francisella, Los Alamos National Laboratory researchers are working to use DNA markers to discern related but relatively harmless species as they are identified and to provide a means to distinguish them from the harmful F. tularensis.
US Department of Homeland Security, Science and Technology Directorate

Contact: Nancy Ambrosiano
nwa@lanl.gov
505-667-0471
DOE/Los Alamos National Laboratory

Public Release: 19-Dec-2016
Nature Chemical Biology
Ancient Chinese malaria remedy fights TB
A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance. In a promising study led by Robert Abramovitch, a Michigan State University microbiologist and TB expert, the ancient remedy artemisinin stopped the ability of TB-causing bacteria, known as Mycobacterium tuberculosis, to become dormant. The study is published in the journal Nature Chemical Biology.
Bill and Melinda Gates Foundation, National Institutes of Health, MSU AgBioResearch

Contact: Sarina Gleason
sarina.gleason@cabs.msu.edu
517-355-9742
Michigan State University

Public Release: 16-Dec-2016
The Lancet
Children dying preventable deaths from congenital heart disease
Over one million children are born with congenital heart disease (CHD) each year, and 90 percent are born in poor regions with little or no access to care. CHD and other serious birth defects are among the top five causes of death of children worldwide. Increasing access to care will save children's lives.

Contact: Faith Adams
faith@childrensheartlink.org
612-423-7125
Children's HeartLink

Public Release: 15-Dec-2016
Scientific Reports
UCLA researchers combat antimicrobial resistance using smartphones
A team of UCLA researchers has developed an automated diagnostic test reader for antimicrobial resistance using a smartphone. The technology could lead to routine testing for antimicrobial susceptibility in areas with limited resources.

Contact: Matthew Chin
mchin@support.ucla.edu
310-206-0680
University of California - Los Angeles

Public Release: 15-Dec-2016
Funding for new treatments for malnourished children
A consortium of researchers including groups from Plymouth University, University College London and Queen Mary University of London have received funding from the Medical Research Council-led Foundation Award with support from the Biotechnology and Biological Sciences Research Council to assess new ways to help severely malnourished children in Zambia and Zimbabwe.
Global Challenges Research Fund

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth

Public Release: 15-Dec-2016
Cancer Epidemiology
Cancer registries in resource-constrained countries can inform policy to reduce cancer burden
Data from population-based cancer registries are vital for informing health programs, policies and strategies for cancer screening and treatment. A special issue of Cancer Epidemiology, prepared under the auspices of the Centers for Disease Control and Prevention, offers lessons for planning and supporting cancer registration in resource-constrained settings to support data-driven policies on cancer prevention, early detection and appropriate treatment leading to significant cost savings for government and society as a whole.

Contact: Sarah Jenkins
sl.jenkins@elsevier.com
44-186-584-3243
Elsevier

Public Release: 15-Dec-2016
PLOS Pathogens
Hormone-disrupting compound could provide new approach to malaria control
A chemical that disrupts biological processes in female mosquitoes may be just as effective as insecticides in reducing the spread of malaria, according to a new study from Harvard T.H. Chan School of Public Health.
Bill & Melinda Gates Foundation

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-8413
Harvard T.H. Chan School of Public Health

Public Release: 14-Dec-2016
Science Advances
Vaccination increases family wealth, girls' education
A Washington State University-led research team found households in rural Africa that vaccinate their cattle for East Coast fever increased their income and spent the additional money on food and education. Researchers also found that when fewer cattle died from the fever, girls were more likely to attend secondary school.
Global Alliance for Livestock Veterinary Medicines, Bill & Melinda Gates Foundation

Contact: Tom Marsh, WSU Allen School
tl_marsh@wsu.edu
509-335-8597
Washington State University

Public Release: 14-Dec-2016
Journal of Public Health
Celebrity chefs have poor food safety practices, a Kansas State University study finds
Kansas State University food safety experts viewed 100 cooking shows with 24 popular celebrity chefs and found several unclean food preparation behaviors. Kansas State University food safety experts Edgar Chambers IV and Curtis Maughan, along with Tennessee State University's Sandria Godwin, recently published 'Food safety behaviors observed in celebrity chefs across a variety of programs' in the Journal of Public Health.

Contact: Edgar Chambers IV
eciv@k-state.edu
785-532-0156
Kansas State University

Public Release: 14-Dec-2016
MBio
UC researchers examine potential drug pathway to combat pneumocystis
A study led by University of Cincinnati researchers is offering new insight in how the fungus Pneumocystis, thrives in the lungs of immune-compromised individuals, where it can cause a fatal pneumonia.
NIH/National Heart, Lung and Blood Institute, US Department of Veterans Affairs

Contact: Cedric Ricks
cedric.ricks@uc.edu
513-558-4657
University of Cincinnati Academic Health Center

Public Release: 14-Dec-2016
The Open Dentistry Journal
Promotion of nickel (Ni) allergy by anamnestic sensitization
This report provides evidence that the solitary pre-sensitization to LPS is essential for the onset of Ni allergy by shifting the Th1/Th2 immune balance toward a Th1 dominant.

Contact: Faizan ul Haq
faizan@benthamscience.org
Bentham Science Publishers

Public Release: 14-Dec-2016
International alliance receives grant to improve cassava harvest and nutrition for farmers in Africa
Scientists under VIRCA Plus are developing improved cassava varieties to enhance the livelihoods and health status of African farm families.
Bill and Melinda Gates Foundation

Contact: Melanie Bernds
mbernds@danforthcenter.org
314-587-1647
Donald Danforth Plant Science Center

Public Release: 14-Dec-2016
The BMJ
Investment in medicine regulatory authorities key to fighting the 21st century 'Third Man'
From Vienna to the Democratic Republic of Congo, fake medicines have threatened citizens across the board -- and borders -- in wartime as well as peacetime. 'Fake Penicillin, The Third Man and Operation Claptrap,' an article published today in BMJ's online Christmas edition, visits the history of falsified drugs and highlights what needs to be done to avert a problem that threatens us all.

Contact: Anne Whitehouse
anne.whitehouse@iddo.org
44-186-561-2948
Infectious Diseases Data Observatory

Public Release: 13-Dec-2016
Could co-infection with other viruses affect the survival of those with Ebola virus?
Could co-infection with other viruses have a detrimental affect on Ebola survival, and why did some show Ebola symptoms without having the virus? A new study investigates.
Public Health England

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth

Public Release: 13-Dec-2016
Cladistics
Mutations acquired trans-Pacific may be key to changes in Zika severity
Though Zika has been known for 70 years, in many ways the virus is still poorly understood. A new phylogenetic and geographic analysis of Zika's collected genetic sequences provides the most complete study of the virus's history to date. The analysis reveals indications of a surprisingly complex global background including an under-recorded ancestry in Asia. Further, the analysis identifies specific mutations in the Pacific transit that suggest possible explanations for Zika's recent virulence.
Defense Advanced Research Projects Agency

Contact: James Hathaway
jbhathaw@uncc.edu
704-687-5743
University of North Carolina at Charlotte

Public Release: 12-Dec-2016
Journal of the American Chemical Society
Groundbreaking study sheds light on treating cancer
The work by Professor Tae-Hyuk Kwon (School of Natural Science) at Ulsan National Institute of Science and Technology, South Korea, has presented a new cancer treatment that uses red lights to target and kill cancer cells alternatively without surgery.
UNIST Alzheimer's Disease Research Fund

Contact: JooHyeon Heo
joohyeonheo@unist.ac.kr
82-522-171-223
Ulsan National Institute of Science and Technology(UNIST)

Showing releases 551-575 out of 1404.

<< < 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 > >>